cefuroxime has been researched along with Cancer of Paranasal Sinus in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The surgeon must administer the drug most suitable for the particular operation and patient at an adequate dosage and over an adequate period." | 2.67 | [Perioperative single dose prevention with cephalosporins in the ENT area. A prospective randomized study]. ( Maier, W; Strutz, J, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maier, W | 1 |
| Strutz, J | 1 |
1 trial available for cefuroxime and Cancer of Paranasal Sinus
| Article | Year |
|---|---|
[Perioperative single dose prevention with cephalosporins in the ENT area. A prospective randomized study].
Topics: Cefuroxime; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Neck Dissection; | 1992 |